Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors von Valachis, Antonios, Rosén, Camilla, Koliadi, Anthoula, Digkas, Evangelos, Gustavsson, Alice, Nearchou, Andreas, Ullenhag, Gustav J

Volltext

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness von Olsson Ladjevardi, Cecilia, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J

Volltext

Predicting immune‐related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study von Olsson Ladjevardi, Cecilia, Koliadi, Anthoula, Rydén, Viktoria, Inan El‐Naggar, Ali, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Volltext

Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years von Wahlin, Björn Engelbrekt, Övergaard, Ninja, Peterson, Stefan, Digkas, Evangelos, Glimelius, Ingrid, Lagerlöf, Ingemar, Johansson, Ann‐Sofie, Palma, Marzia, Hansson, Lotta, Linderoth, Johan, Goldkuhl, Christina, Molin, Daniel

Volltext

Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analy... von Digkas, Evangelos, Tabiim, Anthony Jagri, Smith, Daniel, Valachis, Antonis

Volltext

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer von Ladjevardi, Cecilia Olsson, Skribek, Marcus, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Volltext

Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study von Digkas, Evangelos, Smith, Daniel Robert, Wennstig, Anna-Karin, Matikas, Alexios, Tegnelius, Eva, Valachis, Antonios

Volltext

The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis von Rydén, Viktoria, El‐Naggar, Ali Inan, Koliadi, Anthoula, Ladjevardi, Cecilia Olsson, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Volltext

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting von Joona, Therse Björkin, Digkas, Evangelos, Wennstig, Anna-Karin, Nyström, Karin, Nearchou, Andreas, Nilsson, Cecilia, Pauksens, Karlis, Valachis, Antonis

Volltext

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years von Wahlin, Bjoern Engelbrekt, Overgaard, Ninja, Peterson, Stefan, Digkas, Evangelos, Glimelius, Ingrid, Lagerlöf, Ingemar, Johansson, Ann-Sofie, Palma, Marzia, Hansson, Lotta, Linderoth, Johan, Goldkuhl, Christina, Molin, Daniel

Volltext

Chromosome instability in patients with chronic renal failure von Lialiaris, Theodoros, Mavromatidou, Polyxeni, Digkas, Evangelos, Passadaki, Theoktisti, Mpountoukas, Panagiotis, Panagoutsos, Stylianos, Vargemezis, Vassilios

Volltext

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors : a retrospective cohort study in patients with advanced cancer von Ladjevardi, Cecilia Olsson, Skribek, Marcus, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav

Volltext bestellen

Incidence and risk factors of hypothyroidism after treatment for early breast cancer : a population-based cohort study von Digkas, Evangelos, Smith, Daniel Robert, Wennstig, Anna-Karin, Matikas, Alexios, Tegnelius, Eva, Valachis, Antonios

Volltext bestellen

The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients : A case series and meta-analysis von Rydén, Viktoria, El-Naggar, Ali Inan, Koliadi, Anthoula, Ladjevardi, Cecilia Olsson, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav

Volltext bestellen

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer : association with treatment effectiveness von Ladjevardi, Cecilia Olsson, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav

Volltext bestellen

Cytogenetic damage after ischemia and reperfusion von Lialiaris, Theodore, Kouskoukis, Alexandros, Tiaka, Elisabeth, Digkas, Evangelos, Beletsiotis, Anastasios, Vlasis, Konstantinos, Papathanasiou, Efthymia, Athanassiou, Evangelos, Natsis, Konstantinos

Volltext

Increased Chromosome Fragility in Gastric Cancer Patients von Kouridakis, Petros, Digkas, Evangelos, Kouklakis, Georgios, Minopoulos, Georgios, Polychronidis, Alexandros, Lyratzopoulos, Nikolaos, Lialiaris, Theodoros S

Volltext

Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors : A retrospective cohort study von Ladjevardi, Cecilia Olsson, Koliadi, Anthoula, Rydén, Viktoria, Inan El-Naggar, Ali, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav

Volltext bestellen

Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors von Valachis, Antonios, Rosén, Camilla, Koliadi, Anthoula, Digkas, Evangelos, Gustavsson, Alice, Nearchou, Andreas, Ullenhag, Gustav J

Volltext bestellen

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years von Wahlin, Bjoern Engelbrekt, Övergaard, Ninja, Peterson, Stefan, Digkas, Evangelos, Glimelius, Ingrid, Lagerlöf, Ingemar, Johansson, Ann-Sofie, Palma, Marzia, Hansson, Lotta, Linderoth, Johan, Goldkuhl, Christina, Molin, Daniel

Volltext bestellen